扩散性帕伦基马性肺病:病理生理学和管理方面的最新情况.
1Division of Pulmonary, Critical Care, Sleep Medicine, and Physiology, Department of Medicine, University of California San Diego, La Jolla, California, USA;
Annual review of medicine
|January 27, 2026
概括
由于复杂的原因和诊断,扩散性帕伦基马肺病 (DPLD) 的管理具有挑战性. 了解病理生理学和多学科合作的最新进展改善了这些纤维化肺部疾病的个性化治疗和患者结果.
科学领域:
- 肺部病理学 肺部病理学
- 内部医学 内部医学
背景情况:
- 扩散性帕伦基马肺病 (DPLD) 涵盖了具有复杂病原性的多种炎症-纤维状疾病.
- 患者的异质性和非特异性诊断方法带来了重大管理挑战.
研究的目的:
- 审查最近在流行病学,分类,病理生理学和DPLD的管理方面的进展.
- 突出多学科合作对改善诊断准确性和个性化治疗策略的影响.
主要方法:
- 文献综述,重点关注过去十年的进展.
- 分析当前的治疗选择,包括抗纤维素药物和症状管理.
- 探索正在进行的新型诊断和治疗方法的研究.
主要成果:
- 多学科的合作加强了DPLD的诊断和个性化治疗,从而改善了患者的治疗结果.
- 管理策略现在包括针对性治疗,如抗纤维素药物和综合症状/并发症管理.
- 在了解DPLD病理生理学方面取得了重大进展.
结论:
- 最近的进展为DPLD患者提供了更好的管理和结果.
- 个性化治疗策略,由多学科输入提供信息,对于管理DPLD亚型至关重要.
- 目前正在进行的研究有望为纤维化肺部疾病提供新的诊断工具和治疗方法.
相关概念视频
Peptic Ulcer Disease II: Pathophysiology
2.0K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.0K
Coronary Artery Disease II: Pathophysiology
420
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
420
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
1.6K
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
1.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.4K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.4K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
1.2K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.2K
Diffusion
217.9K
Diffusion is the passive movement of substances down their concentration gradients—requiring no expenditure of cellular energy. Substances, such as molecules or ions, diffuse from an area of high concentration to an area of low concentration in the cytosol or across membranes. Eventually, the concentration will even out, with the substance moving randomly but causing no net change in concentration. Such a state is called dynamic equilibrium, which is essential for maintaining overall...
217.9K


